Summary of PHARMAC decisions

EFFECTIVE 1 April 2021

On this page

New listings 

  • Mesalazine (Pentasa) suppos 1 g, 28 pack
  • Mexiletine hydrochloride (Teva) tab 150 mg and 250 mg – S29 and wastage claimable
  • Aqueous cream (Medco) crm, 500 g
  • Tenoxicam (Tilcotil) tab 20 mg
  • Moclobemide (Aurorix) tab 150 mg
  • Atomoxetine (Strattera) cap 10 mg and 40 mg
  • Mepolizumab (Nucala) inj 100 mg prefilled syringe – Special Authority
    – Retail pharmacy
  • Loratadine (Haylor syrup) oral liq 1 mg per ml, 100 ml
  • Latanoprost with timolol (Arrow - Lattim) eye drops 0.005% with timolol 0.5%, 2.5 ml OP
  • Pharmacy services (BSF Bisoprolol Mylan and BSF Darunavir Mylan) brand switch fee – may only be claimed once per patient
  • Diabetic oral feed 1kcal/ml (Nutren Diabetes) liquid (vanilla), 200 ml OP – Special Authority – Hospital pharmacy [HP3]

Changes to restrictions

  • Omeprazole cap 20 mg (Omeprazole Actavis 20) and cap 40 mg (Omeprazole Actavis 40) – stat dispensing removed
  • SGLT2 inhibitors – amended therapeutic group name and addition of Special Authority
  • Empagliflozin (Jardiance) tab 10 mg and 25 mg – amended Special Authority criteria
  • Empagliflozin with metformin hydrochloride (Jardiamet) tab 5 mg with 500 mg and 1,000 mg metformin hydrochloride and tab 12.5 mg with 500 mg and 1,000 mg metformin hydrochloride – amended Special Authority criteria
  • Potassium chloride (Juno) inj 75 mg per ml, 10 ml – S29 and wastage removed
  • Quinapril tab 5 mg (Arrow-Quinapril 5), tab 10 mg (Arrow-Quinapril 10) and tab 20 mg (Arrow-Quinapril 20) – stat dispensing removed
  • Bisoprolol fumarate (Bisoprolol Mylan) tab 2.5 mg, 5 mg and 10 mg – addition of brand switch fee
  • Zoledronic acid (Zoledronic Acid Mylan) inj 4 mg per 5 ml, vial – amended Special Authority criteria
  • Somatropin (Omnitrope) inj 5 mg, 10 mg and 15 mg cartridge – amended Special Authority criteria
  • Darunavir (Darunavir Mylan) tab 400 mg and 600 mg – addition of brand switch fee
  • Pegylated interferon alfa-2a (Pegasys) inj 180 mcg prefilled syringe
    – amended Special Authority criteria
  • Sertraline (Setrona, Setrona AU and Arrow-Sertraline) tab 50 mg and 100 mg – reinstate stat dispensing
  • Lapatinib ditosylate (Tykerb) tab 250 mg – amended Special Authority criteria and addition of note

Decreased subsidy

  • Ethinyloestradiol with desogestrel (Mercilon 28) tab 20 mcg with desogestrel 150 mcg and 7 inert tab
  • Bendamustine hydrochloride inj 25 mg and 100 mg vial (Ribomustine) and inj 1 mg for ECP (Baxter) 
  • Aciclovir (ViruPOS) eye oint 3%, 4.5 OP
  • Brinzolamide (Azopt) eye drops 1%, 5 ml OP